Metropolis Healthcare is currently trading at Rs. 1666.00, up by 37.00 points or 2.27% from its previous closing of Rs. 1629.00 on the BSE.
The scrip opened at Rs. 1646.00 and has touched a high and low of Rs. 1669.00 and Rs. 1645.00 respectively. So far 332 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 1719.70 on 14-Jan-2020 and a 52 week low of Rs. 904.85 on 14-May-2019.
Last one week high and low of the scrip stood at Rs. 1719.70 and Rs. 1609.15 respectively. The current market cap of the company is Rs. 8329.66 crore.
The promoters holding in the company stood at 57.41%, while Institutions and Non-Institutions held 21.62% and 20.97% respectively.
Metropolis Healthcare has executed Share Purchase and Shareholders' Agreement for the acquisition of 51% shareholding in Shraddha Diagnostic Centre (I). The purpose of the acquisition is to strengthen the presence of the company in the state of Gujarat, India.
Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
